Cohort Studymoderate evidence

Skin Seed Amplification Assay Differentiates Multiple System Atrophy from Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·November 5, 2026·PMID 42984461

Why it matters

Distinguishing multiple system atrophy from Parkinson's disease is clinically challenging, especially early in the disease course. A skin-based assay that differentiates these synucleinopathies could improve diagnostic accuracy, guide prognosis, and inform patient selection for disease-specific therapies.

Infographic summary of Skin Seed Amplification Assay Differentiates Multiple System Atrophy from Parkinson's Disease.
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled